AU Stock MarketDetailed Quotes

Cynata Therapeutics Ltd (CYP)

Watchlist

0.270
+0.005+1.89%

20min DelayTrading Jun 11 12:18 AET

65.73MMarket Cap-5.87P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cynata Therapeutics Ltd (CYP) Key Financial Indicators

CYP Free Cash Flow (FCF)

Interested in knowing about Cynata Therapeutics Ltd's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: AUD

Cumulative Quarterly

CYP Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Cynata Therapeutics Ltd shows that the company's current ratio is 4.40, indicating healthy liquidity.

Currency: AUD

Cumulative Quarterly

CYP Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Cynata Therapeutics Ltd, the quick ratio is 4.24, indicating that the company can meet its short-term debt obligations.

Currency: AUD

Cumulative Quarterly

CYP Return on Equity (ROE)

Want to learn more about the financial health of Cynata Therapeutics Ltd? The latest ROE figure is --, indicating that the company has stable profitability.

Currency: AUD

Cumulative Quarterly

CYP Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Cynata Therapeutics Ltd, the total asset return on investment (ROA) is --.

Currency: AUD

Cumulative Quarterly

CYP Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Cynata Therapeutics Ltd's latest financial report to see how their gross margin is doing - currently at --.

Currency: AUD

Cumulative Quarterly

CYP Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Cynata Therapeutics Ltd, the net profit margin is --, which is a good sign for its profitability.

Currency: AUD

Cumulative Quarterly

Middle East conflict spreads to the stock market! How should investors respond?

Tensions in the Middle East continue to escalate. After Iran shot down a U.S. Apache helicopter, the U.S. military launched retaliatory airs Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm